Metabolically active cells reduce resazurin, which is blue and nonfluorescent, into resorufin, a pink fluorescent product. The resulting fluorescence intensity serves as a quantitative readout of activity in the sample. Comparing fluorescence across treated and untreated biological samples can therefore reveal relative changes associated with metabolism, viability, or cell growth.
Optimization keeps the fluorescent response within a measurable range. If assay conditions produce too little signal, differences between samples may be difficult to distinguish; excessive conversion can cause signal saturation, limiting comparisons among treatments. Appropriate conditions are therefore important for preserving quantitative relationships between cellular activity and measured fluorescence.
Fluorescence provides an indirect estimate based on metabolic activity rather than a direct count of cells. Higher or lower signals can reflect corresponding differences in the activity of the sampled population, supporting comparisons of viability and proliferation. Interpretation should therefore consider that the readout reflects cellular metabolism as the basis for those measurements.
Direct cell counting measures the number of cells, whereas the Resazurin Fluorometric Assay uses fluorescence generated by metabolic conversion as an indirect quantitative readout. Its value lies in providing a scalable alternative for comparing biological samples, particularly when researchers need to evaluate growth, toxicity, or treatment responses across multiple conditions.
A typical workflow exposes biological samples to resazurin, allows incubation so metabolically active cells can convert it to resorufin, and then measures the resulting fluorescence. Researchers compare the measured intensity across samples or treatments. The incubation and assay conditions should be adjusted so the signal remains measurable and does not become saturated.
The method is useful when researchers need to compare how treatments influence cellular metabolic activity, viability, or proliferation. Fluorescence measurements from treated samples can be compared with other assay conditions to quantify response patterns. This supports toxicity studies and drug-response experiments without relying exclusively on direct cell counting.
Yes. The assay supports studies of microbial or mammalian metabolism, as well as broader investigations of cell growth and treatment effects. In either context, fluorescence provides a comparative metabolic readout. Researchers must still optimize conditions for the specific biological samples so the measured response remains quantitative and avoids saturation.